Tagged with RNA

Pharma International Co. (PIC) You took over from your father in 2006. What have been the key milestones & achievements in the company’s development since then and how does your approach differentiate from your father’s? I joined Pharma International in 2006. We had already started our production in 2000. Previously we had a British…

HUYA Bioscience International - China Your business is very much relationship based here in China. You’ve now established a number of relationships with institutes, universities and companies, but I can imagine that breaking into this market and building those relationships was a challenge. How did you grow this business in the early days? The early…

Association of International Pharmaceutical Manufactures (AIPM) When Focus Reports prepared a report on the French pharmaceutical industry in 2009/10, we found that the head of the main multinational pharmaceutical association had taken a career path quite similar to yours: he had been an administrator and head of the regulatory authority; he subsequently left the administration and…

Laboratórios Bernabó Laboratorios Bernabó es una de las empresas farmacéuticas más distinguidos de toda la historia de la Argentina, con más de 70 años en el mercado. ¿Cómo ha cambiado la visión de Bernabó a través de la historia, lugar donde está hoy, y qué papel ha desempeñado en esta evolución? Comence…

Bharat Biotech International Limited If we first take a step back and look at how Bharat Biotech was established, we see quite a remarkable story. It is rather exceptional to see scientists becoming entrepreneurs. What made you this exception, and what drove you to set up Bharat Biotech? I was based in the US…

Malaysia External Trade Development Corporation (MATRADE) How would you describe the operating environment for foreign companies to use the services of Malaysian companies and how can you reassure these multinationals that sufficient intellectual property protection is in place? There are several key factors which make Malaysia a highly conducive environment for foreign companies to carry out…

Shire International Licensing BV Netherlands Shire has many offices in America, Europe, as well as in Singapore, in Japan and in Australia. The group has a vast global network and a strong presence in these four continents. What is the strategic role that Shire Netherlands plays and how does this role fit into the group’s…

Philippine International Trading Corporation (PITC) Ms. Baua, you have been working for quite a long time in the Department of Trade and Industry. Can you please start by giving to our readers an overview of the DTI and the trade profile of the Philippines? Where does PITC fit in this context? The Department of Trade…

IRPMA (International Research-Based Pharmaceu Please describe the activities of the IRPMA to our readers, and explain the membership advantages of your association. Today the IRPMA consists of 37 multinational research-based pharmaceutical manufacturers, as well as some local R&D companies. Also, eleven individual members representing distribution and start-up biotech companies registered IRPMA for their preparation…

Millennium Pharmacon International Millennium Pharmacon International has a long history, starting at its founding in 1952. Could you give our readers an overview of the company’s milestones, particularly those from the past decade? Millennium Pharmacon International, or MPI as is more known, used to be named PT NVPD Soedarpo Corporation Tbk. This is…

VGX International Could you briefly introduce VGX International to our readers, and in particular explain its relation to US-based company VGX Pharmaceutical (VGXP)? The backbone of VGXP is the University of Pennsylvania in terms of the research grant and Dr. David Weiner as the scientific chief of the company and the brain…

International Pharmaceutical Manufacturing Gr Although Indonesia in the last ten years had the second highest growth in ASIA in terms of drugs’ production and consumption, the market share of research based companies has dropped from 50% to 25%. What have been the main drivers leading to the current scenario? The share of international companies…